27 de octubre de 2015
PROPIEDAD INTELECTUAL: TALLER CONJUNTO DE LA OMS, LA OMPI Y LA OMC

Taller sobre los criterios de patentabilidad

El 27 de octubre de 2015 se celebró un taller técnico sobre los criterios de patentabilidad, organizado conjuntamente por la Organización Mundial de la Salud, la Organización Mundial de la Propiedad Intelectual y la OMC. En el taller los participantes adquirieron nociones concretas sobre el modo en que se aplican los principales criterios sustantivos de patentabilidad en la práctica en los distintos países, y acerca de la forma en que las diversas definiciones e interpretaciones pueden repercutir en la salud pública.

English only

Véase también:

The aim was to support participants to engage in a policy debate that is characterized by its highly technical nature and assist them to appropriately frame and assess national patent systems and practices. To do so, the three collaborating agencies provided a brief overview of the legal framework at multilateral, regional and national level. This was followed by an interactive session led by a practitioner who presented and discussed a number of practical cases. The final discussion provided an opportunity to look at matters of public interest and concerns with respect to the design and application of patentability criteria at country level and potential repercussions on public health.

The Workshop took place back to back with the WHO-WIPO-WTO Symposium on “Public Health, Intellectual Property, and TRIPS at 20: Innovation and Access to Medicines; Learning from the Past, Illuminating the Future” that was held at the WTO on 28 October 2015.

PROGRAMME

14h00 — 14h10

Welcome and introduction

14h10 — 15h15

Patentability criteria and public health

    Patentability criteria pursuant to the TRIPS Agreement
    Roger Kampf, Counsellor, Intellectual Property Division, WTO
    Presentation

    Patentability criteria and patent grant procedures at country level
    Tomoko Miyamoto, Head, Patent Law Section, WIPO
    Presentation

    Impact of patentability criteria on public health
    Peter Beyer, Senior Advisor, Department of Essential Medicines & Health Products, WHO       
    Presentation    

Q&A

Audio

15h15 — 17h00

Application of patentability criteria to concrete pharmaceutical patent cases

    Markus Engelhard, Boehmert & Boehmert, Munich/Germany
    Presentation

Audio

17h00 — 18h00

Open discussion on patentability criteria and domestic needs

    Moderator: Antony Taubman, Director, Intellectual Property Division, WTO

Audio